Exosomes are small vesicles involved in cell signalling. Commercial products are studied for regenerative medicine and hair loss, but they differ in source, manufacturing, concentration, testing and regulatory status. Treatment is a product-specific medical decision, not a guaranteed regrowth method. Diagnosis comes first, and the exact product must be identified before its benefits, limits and safety are discussed.
Exosomes are membrane-bound particles released by cells that carry proteins, lipids and nucleic-acid signals. Commercial preparations are being investigated for several regenerative uses, including hair loss.
In aesthetic practice, an exosome product may be applied to the scalp according to a clinic protocol. "Exosome" does not describe one standard medicine, as cell source, purification, concentration and quality control vary by product.
Plan Your Exosome Therapy Around the Right Assessment
The consultation reviews the diagnosis, stage of thinning, scalp condition, past treatments and whether follicles remain in the target area. The doctor explains alternatives and why an exosome product is proposed. Patients should receive the product name, biological source, manufacturer, quality and testing details, intended use, known risks and the clinic's session protocol. If these are unclear, treatment should not be promoted with broad "stem-cell" or "regenerative" claims alone.
Watch the Explanation
Exosome treatment is considered only after the type and stage of hair loss have been assessed.
Exosome products are not interchangeable, so their source, processing and quality controls must be clear.
Terms like "approved", "stem-cell therapy" or "clinically proven" need product-specific verification before use.
Exosome injections should not be presented as creating new follicles in a completely bald area.
Photographs and scalp assessment allow a more objective review of response.
PRP, GFC, medication, LLLT and transplantation differ in evidence, cost and indications, and patients should understand them.
OUR PROCESS
The type and stage of hair loss are established before treatment is considered.
The product's source, manufacturer, intended use, uncertainties and alternatives are explained.
Standardised photos and relevant scalp findings are recorded.
The treatment area is prepared using sterile technique.
The verified product is delivered according to the clinic's confirmed protocol.
Patients receive scalp-care instructions and guidance on when to report unexpected reactions.
Progress is assessed before any further or maintenance treatment is recommended.
Patients with living, miniaturised follicles may be considered after diagnosis.
Exosome therapy may be discussed alongside established options, with a clear explanation of the uncertainty in the evidence.
Combination treatment needs a defined clinical rationale and should not be bundled automatically.
Response tracking is essential when using an emerging treatment with variable evidence.
Product-specific contraindications, pregnancy, immune or medical conditions, active scalp disease and allergy risk require clinician review.
Our Doctors
Senior Consultant Dermatologist, Cosmetic Expert & Hair Transplant Surgeon
Meet the Hair Restoration Expert
Dr Sandeep Mahapatra founded NeoSculpt6 and is a Senior Consultant Dermatologist with over 20 years of clinical experience in hair restoration and hair transplantation.
His approach focuses on diagnosis, donor conservation, natural hairline design, personalised planning and long-term hair-restoration strategy.
What Determines Exosome Therapy Cost? Cost depends on the number of recommended sessions, severity of hair loss, scalp condition, treatment goals and whether combination therapy is needed.
Recommendations vary with hair-loss stage, scalp health and response goals.
The extent and pattern of thinning shape how therapy is planned.
The plan may focus on density support, scalp health or combined care, based on assessment findings.
Exosome therapy may be combined with PRP, GFC, medication or other options where appropriate.
Research is still developing, and the evidence does not reliably promise regrowth for every patient or show that exosomes outperform established therapies. They should not replace a transplant in areas without viable follicles.
Rated 4.8 on Google from 1,042 reviews of Neo Follicle
Have a Question?
It uses products containing extracellular vesicle-related signalling components and is positioned as regenerative support in selected hair-loss cases.
No. Exosomes are not living stem cells, and patients should be told exactly which product is used and which claims apply to it.
It may be discussed for selected thinning patterns where follicles are still active. Suitability depends on diagnosis, scalp condition, medical history and available evidence.
Research is emerging and protocols vary. Results cannot be guaranteed, and the doctor should explain the expected role and limits.
They should not be expected to create follicles where none exist. A transplant may be more relevant for stable bald areas.
Downtime usually relates to scalp delivery, such as tenderness or redness, and varies by method. Clinic aftercare instructions apply.
Combination may be considered when clinically justified and should fit the diagnosis and long-term restoration plan.
Emerging Treatments Require More Transparency, Not More Hype
NeoSculpt6 will assess your diagnosis and explain the proposed product, what is known, what remains uncertain and which alternatives may suit your hair-loss pattern.
